[1]刘建军,曾贤翠,郝淑萍,等.腹水超滤浓缩回输联合中医辨证治疗肝硬化顽固性腹水40例临床观察[J].西部中医药,2013,26(06):1-3.
　LIUJianjun,ZENGXiancui,HAOShuping,et al.ClinicalObservationonUltrafiltrationReinfusionofConcentratedAscitesandSyndromeDifferentiationforRefractoryAscitesofLiverCirrhosis:AReportof40Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(06):1-3.
点击复制

腹水超滤浓缩回输联合中医辨证治疗肝硬化顽固性腹水40例临床观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年06期
页码:
1-3
栏目:
出版日期:
2013-06-15

文章信息/Info

Title:
ClinicalObservationonUltrafiltrationReinfusionofConcentratedAscitesandSyndromeDifferentiationforRefractoryAscitesofLiverCirrhosis:AReportof40Cases
文章编号:
1004-6852(2013)06-0001-03
作者:
刘建军，曾贤翠，郝淑萍，牛变彩，陈爱英，史德娣，李晶
甘肃省中医院白银分院，甘肃白银730900
Author(s):
LIUJianjun,ZENGXiancui,HAOShuping,NIUBiancai,CHENAiying,SHIDedi,LIJing
BaiyinBranchofGansuProvinceHospitalofTraditionalChineseMedicine,Baiyin730900,China
关键词:
顽固性腹水; 肝硬化; 腹水超滤浓缩回输; 辨证论治
Keywords:
refractory ascites;  liver cirrhosis;  ultrafiltration reinfusion of concentrated ascites; syndrome differentiation and treatment
分类号:
R442.5
文献标志码:
A
摘要:
目的：观察腹水超滤浓缩回输腹腔联合中医辨证治疗肝硬化顽固性腹水的临床疗效及不良反应。方法：将80例肝硬化顽固性腹水患者随机分为治疗组和对照组各40例。对照组采用附子理中汤合五苓散 加减治疗；治疗组在对照组基础上采用WLFHY-500型伟力电脑腹水超滤浓缩回输系统进行腹水超滤浓缩回输腹腔治疗。结果：2组治疗后患者腹围、体质量均有明显下降(P＜0.01)，尿量均有明显增加(P＜0.01)，但治疗组较对照组在腹围、体质量下降和尿量增加方面尤为明显(P＜0.05)。2组治疗前后血浆中钾、钠、氯、钙无明显变化(P＞0.05)，白蛋白有所升高(P＜0.01)，而治疗组升高较为明显(P＜0.05)。总有效率、不良反应发生率治疗组分别为82.8%、7.5%，对照组分别为60.5%和5%。2组总有效率相比差异显著(P＜0.05),不良反应发生率差异无显著性(P＞0.05)。结论：腹水超滤浓缩回输联合中医辨证治疗是治疗肝硬化顽固性腹水。
Abstract:
Objective: To observe clinical efficacy and adverse reactions of ultrafiltration reinfusion of concentrated ascites and syndrome differentiation in treating refractory ascites of liver cirrhosis. Method: All 80 patients were randomized into the treatment group and the control group. The control group took modified FuZi LiZhong Tang and Wu Ling San; besides the therapy given to the control group, the treatment group received ultrafiltration reinfusion treatment of concentrated ascites. Result: Abdominal girth and body weight of the patients were decreased significantly after treating(P＜0.01), urinary volume was increased remarkably(P＜0.01), but the treatment group improved greater than the control group in the decrease of abdominal girth and body weight, the increase of urinary volume (P＜0.05). Potassium, sodium, chlorine and calcium in the plasma showed no changes before and after treating in both groups (P＞ 0.05), albumin was improved (P＜0.01), and the treatment group was improved more significantly (P＜0.05). Total effective rate and the incidence of adverse reaction of the treatment group were 82.8% and 7.5%, higher than 60.5% and 5% of the control group, the difference in total effective rate was significant between both groups (P＜0.05), the difference was not significant in the incidence of adverse reaction (P＞ 0.05). Conclusion:Ultrafiltration reinfusion of concentrated ascites and syndrome differentiation are an emethod in treating refractory ascites of liver cirrhosis.

相似文献/References:

[1]黄鸿娜,黄晶晶△,王振常,等.柔肝化纤颗粒治疗肝硬化脾功能亢进症的临床观察[J].西部中医药,2014,27(09):111.
[2]张萍,朱建坤.肝硬化患者应用中医食疗的临床护理分析[J].西部中医药,2013,26(07):112.
　ZHANG Ping,ZHU Jiankun.Analysis on Clinical Nursing for Liver Cirrhosis Patients Given with TCM Food Therapy[J].Western Journal of Traditional Chinese Medicine,2013,26(06):112.
[3]樊红,冯彦虎,张德奎△,等.中西医结合治疗肝炎后肝硬化腹水疗效观察[J].西部中医药,2013,26(02):91.
　FAN Hong,FENG Yanhu,ZHANG Dekui,et al.Clinical Observation on Integrative Medicine in Treating Cirrhosis Ascites of Patients with Hepatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(06):91.
[4]闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(07):84.
　YAN Xuehua.Clinical Observation on Entecavir Combined with Compound BieJia RuanGan Tablets in Treating Decompensated Liver Cirrhosis of Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2014,27(06):84.
[5]龚红霞,邱晶.多层螺旋CT门静脉成像在肝硬化中医证型诊断中的应用价值[J].西部中医药,2018,31(12):147.
　GONG Hongxia,QIU Jing.Application Value of Multilayer Spiral CT Portal Vein Imaging in the Diagnosis of TCM Patterns of Liver Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2018,31(06):147.
[6]朱艳国,朱艳丽△,张金花.自拟化积膏治疗肝硬化疗效观察[J].西部中医药,2019,32(05):63.
　ZHU Yanguo,ZHU Yanli,ZHANG Jinhua.Clinical Observation on Selfmade HuaJi Ointment in Treating Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2019,32(06):63.
[7]陈美岑,等.柔肝化纤颗粒对失代偿期肝硬化患者肠道菌群的影响[J].西部中医药,2021,34(12):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
　CHEN Meicen,WANG Zhenchang,et al.Effects of Rougan Huaxian Granules on Intestinal Flora in Patients with Decompensated Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2021,34(06):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
[8]徐婷婷,安振涛,李慧,等.肝硬化腹水证治分布及脐敷疗法用药规律文献研究[J].西部中医药,2021,34(06):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]
　XU Tingting,AN Zhentao,LI Hui,et al.Literature Study on the Distribution of Syndrome Differentiation and Treatment of Cirrhosis Ascites and Medication Rules of Umbilical Compressing Therapy[J].Western Journal of Traditional Chinese Medicine,2021,34(06):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]
[9]马玉珍,毛德文,覃艳新,等.六味醒神颗粒治疗肝硬化轻微型肝性脑病的临床疗效及其对血氨和内毒素的影响[J].西部中医药,2021,34(05):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
　MA Yuzhen,MAO Dewen,QIN Yanxin,et al.Clinical Effects of Liuwei Xingshen Granules in Treating Mild Hepatic Encephalopathy of Liver Cirrhosis and Its Influence on Blood Ammonia and Endotoxin[J].Western Journal of Traditional Chinese Medicine,2021,34(06):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
[10]吴铁雄,刘旭东,朱沪敏,等.大黄?虫胶囊联合心得安治疗乙肝肝硬化门脉高压症临床观察[J].西部中医药,2023,36(02):102.[doi:10.12174/j.issn.2096-9600.2023.02.23]
　WU Tiexiong,LIU Xudong,ZHU Humin,et al.Clinical Observation on Dahuang Zhechong Capsules and Propranolol in the Treatment of Portal Hypertension of Hepatitis B Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2023,36(06):102.[doi:10.12174/j.issn.2096-9600.2023.02.23]

备注/Memo

备注/Memo:
收稿日期：2012-12-04 作者简介：刘建军(1967—)，男，副主任医师，甘肃省医学会感染病学分会委员会委员。研究方向：慢性肝炎、肝硬化的临床诊治。
更新日期/Last Update: 2013-06-15